Prof. Dr. Mahmoud Omar | Analytical Chemistry | Best Researcher Award

Prof. Dr. Mahmoud Omar | Analytical Chemistry | Best Researcher Award

Prof. Dr. Mahmoud Omar , Faculty of pharmacy, Taibah University , Egypt

Dr. Mahmoud Ahmed Omar Hassan is a distinguished Professor specializing in Pharmacognosy and Pharmaceutical Chemistry. Currently serving at the College of Pharmacy, Taibah University, Saudi Arabia, he brings extensive expertise in analytical chemistry and pharmaceutical sciences. His research emphasizes innovative analytical methods and the determination of pharmaceutical compounds in diverse matrices. With over two decades of teaching and research, Dr. Hassan has significantly contributed to pharmacy education, mentoring students in analytical and pharmaceutical chemistry. He is widely published, with impactful work on spectro fluorimetry, spectrophotometry, chromatography, and voltammetry. His contributions enhance drug quality assurance and pharmaceutical analysis.

Professional Profile

Google Scholar

Scopus

Summary of Suitability for Award:

Dr. Mahmoud Ahmed Omar Hassan is an exemplary candidate for the “Best Researcher Awards” due to his extensive contributions to pharmaceutical analytical chemistry. With over 25 years of experience in academia and research, he has demonstrated unparalleled expertise in developing innovative analytical methods. His research addresses critical challenges in drug analysis, including determination in pharmaceutical formulations and biological fluids, with a strong focus on green chemistry and quality assurance. Dr. Hassan’s prolific publication record includes high-impact articles in peer-reviewed journals, showcasing groundbreaking work in spectrofluorimetry, chromatography, and photoluminescence. He has also been a mentor and educator, teaching advanced courses and shaping future scientists.

🎓Education:

Dr. Mahmoud Ahmed Omar Hassan holds a Ph.D. in Pharmaceutical Sciences (Pharmaceutical Analytical Chemistry) from Minia University, Egypt, completed in 2005. His doctoral research emphasized advanced analytical techniques for pharmaceutical applications. He earned his Master’s degree in Pharmaceutical Sciences (Pharmaceutical Analytical Chemistry) from Assiut University, Egypt, in 1999, focusing on drug analysis and quality control. He began his academic journey with a Bachelor’s degree in Pharmaceutical Sciences from Al-Azhar University, Egypt, in 1994. His comprehensive educational foundation underpins his expertise in analytical chemistry, making him a leader in pharmaceutical education and research.

🏢Work Experience:

Dr. Hassan’s career spans over 25 years in academia and research. He started as a Demonstrator at Al-Azhar University in 1995, progressing to Associate Lecturer by 1999. He joined Minia University in 1999, where he served as an Assistant Professor until 2010, later becoming an Associate Professor (2010–2015) and Professor (2015–2019). In 2019, he joined Taibah University, Saudi Arabia, as a Professor in the Pharmacognosy and Pharmaceutical Chemistry Department, where he teaches pharmaceutical analytical chemistry and technology courses. His vast teaching experience and mentorship have shaped future leaders in pharmaceutical sciences.

🏅Awards: 

Dr. Hassan has been recognized for his contributions to pharmaceutical sciences and education. He received accolades for research excellence at Minia University and was honored at Taibah University for advancing pharmaceutical analysis techniques. His innovative teaching methods and mentorship earned him recognition from students and academic institutions alike. Dr. Hassan’s achievements reflect his dedication to advancing analytical chemistry and his impactful role in enhancing pharmaceutical education and research.

🔬Research Focus:

Dr. Hassan specializes in developing innovative analytical methods for pharmaceutical analysis. His work focuses on determining drugs in pure forms, pharmaceutical formulations, and biological fluids using advanced techniques like spectrofluorimetry, spectrophotometry, voltammetry, and chromatography. He is committed to promoting green analytical chemistry and improving drug quality assurance practices. His research aims to address global challenges in pharmaceutical analysis, ensuring the efficacy and safety of drugs.

Publication Top Notes:

Use of charge-transfer complexation in the spectrophotometric analysis of certain cephalosporins

Authors: GA Saleh, HF Askal, MF Radwan, MA Omar

Citations: 159

Year: 2001

Kinetic spectrofluorimetric determination of certain cephalosporins in human plasma

Authors: MA Omar, OH Abdelmageed, TZ Attia

Citations: 88

Year: 2009

Development and validation of HPLC method for simultaneous determination of amlodipine, valsartan, hydrochlorothiazide in dosage form and spiked human plasma

Authors: EG Samya M, A Osama H, D Sayed M

Citations: 77

Year: 2012

Validated spectrofluorimetric method for determination of selected aminoglycosides

Authors: MA Omar, HM Ahmed, MA Hammad, SM Derayea

Citations: 54

Year: 2015

Development of spectrofluorimetric method for determination of certain aminoglycoside drugs in dosage forms and human plasma through condensation with ninhydrin and phenyl

Authors: MA Omar, MA Hammad, DM Nagy, AA Aly

Citations: 51

Year: 2015

Development and validation of a new spectrofluorimetric method for the determination of some beta-blockers through fluorescence quenching of eosin Y. Application to content

Authors: SM Derayea, MA Omar, MAK Abdel-Lateef, AI Hassan

Citations: 48

Year: 2016

Spectrophotometric and spectrofluorimetric determination of certain diuretics through ternary complex formation with eosin and lead (II)

Authors: MA Omar

Citations: 42

Year: 2010

Kinetic spectrophotometric determination of certain cephalosporins in pharmaceutical formulations

Authors: MA Omar, OH Abdelmageed, TZ Attia

Citations: 37

Year: 2009

Validated spectrophotometric methods for determination of certain aminoglycosides in pharmaceutical formulations

Authors: MA Omar, DM Nagy, MA Hammad, AA Aly

Citations: 35

Year: 2013

Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination

Authors: SM Derayea, MA Omar, AA Abu-Hassan

Citations: 33

Year: 2018

 

 

 

 

 

 

Assoc. Prof. Dr. Sherif Shawky | Analytical Chemistry Award | Best Researcher Award

Assoc. Prof. Dr. Sherif Shawky | Analytical Chemistry Award | Best Researcher Award

Assoc. Prof. Dr. Sherif Shawky , Misr Univeristy For Science and Technology , Egypt 

Assoc. Prof. Dr. Sherif Shawky is an expert in cell biology, nanobiotechnology, and molecular diagnostics. With a background in pharmacy and biotechnology, he has held faculty and research positions at leading institutions, including the University of Connecticut, Misr University for Science and Technology, and Zewail City of Science and Technology. His work focuses on CRISPR-based assays, nanoparticles, and microfluidic platforms for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. Dr. Shawky has been involved in numerous research projects and has contributed significantly to both academia and entrepreneurship. He has been awarded prestigious fellowships, including the Royal Academy of Engineering’s Leaders Innovation Fellowship, and has mentored many students and professionals in the field.

Professional Profile:

Google Scholar 

Summary of Suitability for Award:

Assoc. Prof. Dr. Sherif Shawky is highly suitable for the “Best Researcher Awards” due to his remarkable contributions to the fields of cell biology, nanobiotechnology, and molecular diagnostics. He holds a Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands, and has an extensive background in the development of advanced diagnostic tools, specifically focusing on diseases like Hepatitis C, Alzheimer’s, and various types of cancer. His innovative work in the design and application of nanomaterials, including nanoparticles (such as silica, gold, magnetic, and carbon dots), in biosensors and point-of-care diagnostic devices has had a significant impact on early detection and quantification of biomarkers related to cancer, liver diseases, and neurodegenerative conditions.

🎓Education:

Assoc. Prof. Dr. Sherif  Shawky  earned his Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands . He also holds a Master’s in Biomolecular Sciences from the Free University Amsterdam, specializing in Molecular Cell Biology . He completed his Bachelor of Pharmacy at Misr University for Science and Technology, Egypt. His academic journey has been marked by significant research contributions in the areas of molecular diagnostics, drug delivery, and biosensors, culminating in innovative diagnostic technologies.

🏢Work Experience:

Assoc. Prof. Dr. Sherif  Shawky  has extensive experience as a Research Assistant Professor at the University of Connecticut (UCONN), working on CRISPR-based assays for Alzheimer’s disease diagnosis. He is an Associate Professor of Biochemistry and Entrepreneurship at Misr University for Science and Technology, where he focuses on the development of smart drug delivery systems. His postdoctoral work at Zewail City involved pioneering nanoparticle-based assays for the detection of viral RNA and cancer biomarkers. He is also a Visiting Scholar at Zewail City, where he leads cutting-edge diagnostics projects.

🏅Awards:

Assoc. Prof. Dr. Sherif  Shawky  has received several prestigious awards for his research and entrepreneurial initiatives. He was selected as a Fellow by the Royal Academy of Engineering, where he also secured second place in the final pitch of the Leaders Innovation Fellowship. His entrepreneurial skills were further recognized when he won first place in the final pitch of the Innovate Egypt Program, a joint initiative by VENTUREWELL, USAID, and the National Academy of Science. Shawky’s innovative contributions have also earned him a mentorship role in various incubators and pre-incubators in Egypt, where he guides aspiring entrepreneurs. He has been recognized for his work in disability inclusion and reducing inequalities in healthcare. These honors highlight his excellence in both scientific research and entrepreneurial ventures, showcasing his commitment to advancing health technologies, biosensors, and nanotechnology. Shawky’s multifaceted work continues to have a lasting impact in both academia and industry.

🔬Research Focus:

Assoc. Prof. Dr. Sherif  Shawky research focuses on the development of nanotechnology-based diagnostic tools for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. He specializes in CRISPR/Cas technology, nanoparticle synthesis, and microfluidic chip design. His work on integrating nanoparticles with electrochemical, fluorescence, and colorimetric techniques has led to innovative point-of-care devices for viral RNA quantification and cancer biomarkers. His efforts aim to revolutionize diagnostic technologies for clinical applications.

Publication Top Notes:

  1. Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles
    • Citations: 141
  2. Nucleic acids biosensors based on metal-organic framework (MOF): Paving the way to clinical laboratory diagnosis
    • Citations: 112
  3. Gold aggregating gold: a novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samples
    • Citations: 85
  4. A novel HCV electrochemical biosensor based on a polyaniline@Ni-MOF nanocomposite
    • Citations: 77
  5. A novel Ag/Zn bimetallic MOF as a superior sensitive biosensing platform for HCV-RNA electrochemical detection
    • Citations: 56